FindTrial
Sign In

Comparison of Ondansetron at two different doses versus a placebo to decrease spinal induced hypotension and shivering

Comparison of Ondansetron at two different doses versus a placebo to attenuate spinal induced hypotension and shivering

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046477
Enrollment
225
Registered
2022-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Administration of intravenous Ondansetron prior to administartion of spinal anaesthesia: Intravenous Ondansetron at two different doses(either 4mg or 8mg)will be administered to the pat

Sponsors

Goa Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients requiring spinal anaesthesia for elective or emergency surgical procedures of ASA grade I and II

Exclusion criteria

Exclusion criteria: Contraindications to spinal anaesthesia Previous history of allergy to drugs used Heart disease Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To determine whether administartion of Intravenous Ondansetron has a role in attenuation of spinal induced hypotension and shivering. The following parameters will be assessed : 1.The height of sensory blockade 2.Heart Rate 3.Blood Pressure and Mean Arterial Pressure 4.Presence of shiveringTimepoint: Baseline, at 5 minutes, 10 minutes, 15 minutes, 20 minutes and 25 minutes—

Secondary

MeasureTime frame
not applicableTimepoint: not applicable—

Countries

India

Contacts

Public ContactAveryl Sasha Pinto

Goa Medical College and Hospital, Bambolim, Goa

drsharmila_borkar@yahoo.com9922851257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026